FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pharm D Solutions Trimix QM10 Papaverine 30 mg/Phentolamine 4 Recall

Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable,…

Pharm D Solutions, LLC · Houston, TX

Risk level
Class II
Reported by FDA
Nov 7, 2018
Recall ID
D-0194-2019
Check your lot numberHow we source this data

Summary

Pharm D Solutions recalled Trimix QM10 Papaverine 30 mg/Phentolamine 4 starting Sep 10, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0194-2019 on Nov 7, 2018. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05

Lot numbers, UPCs & expiration codes

Lot: 04262018:09 Discard by: 10/22/2018; 07022018:48 Discard by: 12/29/2018

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0194-2019
Classification
Class II
Status
Terminated
Recall initiated
Sep 10, 2018
FDA report date
Nov 7, 2018
Quantity
9 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pharm D Solutions, LLC

Original FDA data

Every field from FDA enforcement report D-0194-2019, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Terminated
Country
United States
Event ID
81002
Address
1304 S Loop W
Code information
Lot: 04262018:09 Discard by: 10/22/2018; 07022018:48 Discard by: 12/29/2018
Postal code
77054-4010
Report date
Nov 7, 2018
Product type
Drugs
Recall number
D-0194-2019
Classification
Class II
Recalling firm
Pharm D Solutions, LLC
Product quantity
9 vials
Termination date
Feb 5, 2021
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05
Distribution pattern
Nationwide
Recall initiation date
Sep 10, 2018
Initial firm notification
Press Release
Center classification date
Nov 1, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0194-2019, published Nov 7, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls